- Home
- PDLB vs PRQR Comparison
PDLB vs PRQR Comparison
Compare PDLB & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDLB
- PRQR
- Stock Information
- Founded
- PDLB 1960
- PRQR 2012
- Country
- PDLB United States
- PRQR Netherlands
- Employees
- PDLB N/A
- PRQR N/A
- Industry
- PDLB
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- PDLB
- PRQR Health Care
- Exchange
- PDLB Nasdaq
- PRQR Nasdaq
- Market Cap
- PDLB 328.3M
- PRQR 232.8M
- IPO Year
- PDLB 2017
- PRQR 2014
- Fundamental
- Price
- PDLB $14.76
- PRQR $2.06
- Analyst Decision
- PDLB
- PRQR Strong Buy
- Analyst Count
- PDLB 0
- PRQR 8
- Target Price
- PDLB N/A
- PRQR $8.88
- AVG Volume (30 Days)
- PDLB 28.1K
- PRQR 368.1K
- Earning Date
- PDLB 10-29-2025
- PRQR 11-06-2025
- Dividend Yield
- PDLB N/A
- PRQR N/A
- EPS Growth
- PDLB 83.78
- PRQR N/A
- EPS
- PDLB 0.71
- PRQR N/A
- Revenue
- PDLB $90,513,000.00
- PRQR $20,129,184.00
- Revenue This Year
- PDLB $10.97
- PRQR N/A
- Revenue Next Year
- PDLB $8.59
- PRQR N/A
- P/E Ratio
- PDLB $20.81
- PRQR N/A
- Revenue Growth
- PDLB 15.50
- PRQR 8.65
- 52 Week Low
- PDLB $10.88
- PRQR $1.07
- 52 Week High
- PDLB $15.21
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- PDLB 53.05
- PRQR 42.63
- Support Level
- PDLB $14.66
- PRQR $1.91
- Resistance Level
- PDLB $14.96
- PRQR $2.50
- Average True Range (ATR)
- PDLB 0.21
- PRQR 0.16
- MACD
- PDLB -0.04
- PRQR -0.04
- Stochastic Oscillator
- PDLB 25.00
- PRQR 25.42
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.